The short version
- Why people research itSustained GH/IGF-1 elevation for recovery, sleep and lean-mass support.
- What the evidence isDevelopment was discontinued.
- What to watchPuffy hands and a ring that stops fitting.
How CJC-1295 W/ Dac works
Long-acting GHRH analog; the DAC binds albumin so it sustains GH/IGF-1 elevation for days rather than pulsing.
The DAC is one chemical group, and everything that separates this product from the version without it follows from that group’s reaction chemistry. The molecule is the same tetrasubstituted GHRH(1-29) analog with a lysine added at position 30, and on that lysine’s side chain a maleimidopropionic acid group.
Read the word ‘covalently’ carefully, because it is the whole page. A maleimide and a thiol undergo Michael addition to form a thioether — a carbon–sulfur single bond that does not come apart. Human serum albumin carries exactly one free cysteine, Cys34, and it is the most abundant free thiol in plasma.
- Injectable
Research on CJC-1295 W/ Dac5 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Human clinical evidence
Development was discontinued.
One death occurred in a trial of a related ConjuChem compound, which is frequently cited about CJC-1295 itself and is worth stating carefully: it was not this molecule, and the causal link was never established.
Correlative data
Used far less than the no-DAC version, and the reported reason is the mechanism rather than fashion — a week-long elevation produces more water retention, more numbness and tingling, and more of the lethargy people associate with a flat GH curve.
How the mechanism reads
The Drug Affinity Complex binds the peptide to serum albumin, extending its half-life from ~30 minutes to roughly 6–8 days.
MechanisticThis is the clearest mechanism-versus-marketing case in the GH category. A continuous GH elevation is not a bigger version of a pulse — it is a different physiological state, it blunts the natural pulsatility that receptor sensitivity depends on, and it is the same continuous-signaling problem that shows up as insulin resistance with MK-677.
Mechanistic
Sources
- Teichman SL, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. Journal of Clinical Endocrinology and Metabolism 2006 · PMID 16352683
- Ionescu M, Frohman LA. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. Journal of Clinical Endocrinology and Metabolism 2006 · PMID 17018654
- Timms M, et al. An immuno polymerase chain reaction screen for the detection of CJC-1295 and other growth-hormone-releasing hormone analogs in equine plasma. Drug Testing and Analysis 2019 · PMID 30489688
- Memdouh S, et al. Advances in the detection of growth hormone releasing hormone synthetic analogs. Drug Testing and Analysis 2021 · PMID 34665524
CJC-1295 W/ Dac safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Active cancer, because the albumin-bound form keeps IGF-1 elevated for days.
- Diabetes or insulin resistance that is not controlled.
- Heart failure or fluid retention conditions.
- Untreated sleep apnea or carpal tunnel syndrome.
- Pregnancy, or growth still open in a teenager, given a multi-day GH signal.
What’s expected
- IGF-1 stays elevated for days, shown in the original human study.
- Rises in baseline GH between pulses while pulsatility persists.
- Fluid retention, flushing and site reactions.
Watch for
- Puffy hands and a ring that stops fitting.
- Night-time hand numbness.
- Rising fasting glucose or increased thirst.
Labs that tell you it’s working
- IGF-1: stays raised for the whole exposure, so a draw is an on-drug value, not a baseline.
- Growth Hormone, Serum: a random draw reads higher because trough GH rises.
- Insulin (Fasting): sustained GH exposure pushes insulin resistance.
- HbA1c: confirms the glucose cost over months.
GHRH analog covalently bound to albumin through DAC: prolonged GH and IGF-1 elevation that cannot be withdrawn at once. PMID 16352683 PMID 17018654
Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
CJC-1295 W/ Dac FAQ4 common questions
- Is CJC-1295 W/ Dac approved for human use?
- No. CJC-1295 W/ Dac is a research compound.
- What is CJC-1295 W/ Dac researched for?
- Sustained GH/IGF-1 elevation for recovery, sleep and lean-mass support.
- Which labs show whether it's doing anything?
- IGF-1; Growth Hormone, Serum; Insulin; HbA1c: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for CJC-1295 W/ Dac: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.




